Molecular Cytogenetics Market by Product (Kit, Reagent, Probe, Consumable, Software, Service), Technique (In-Situ, FISH, Comparative Genomic Hybridization), Application (Cancer, Genetic), End User (Research Labs, Institutes) - Forecast to 2021

分子細胞遺伝学の世界市場予測(~2021):製品別(キット、試薬、プローブ、消耗品、ソフトウェア、サービス)、技術別(ハイブリダイゼーション法(In-Situ)、蛍光染色体ハイブリッド形成(FISH)、比較ゲノムハイブリダイゼーション)、用途別(がん、遺伝)、エンドユーザー別(研究室、研究機関)

◆タイトル:Molecular Cytogenetics Market by Product (Kit, Reagent, Probe, Consumable, Software, Service), Technique (In-Situ, FISH, Comparative Genomic Hybridization), Application (Cancer, Genetic), End User (Research Labs, Institutes) - Forecast to 2021
◆商品コード:MAM-BT-4883
◆調査・発行会社:MarketsandMarkets
◆発行日:2017年1月26日
◆ページ数:149
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:バイオ技術
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥638,450見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥751,450見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥920,950見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、分子細胞遺伝学の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品別分析、技術別分析、用途別分析、需要先別分析、分子細胞遺伝学の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

The molecular cytogenetics market is projected to reach USD 2.52 billion by 2021 from USD 1.55 billion in 2016, at a CAGR of 10.1% from 2016 to 2021. The global molecular cytogenetics market is segmented based on product, technique, application, end user, and region. The kits and reagents segment is expected to register the highest growth rate in the molecular cytogenetics market, by product, during the forecast period. The high growth in this segment is attributed to the increasing number of rental agreements and increasing incidence of genetic disorders and cancer worldwide. However, the high cost of advanced instruments in emerging economies is restraining the growth of this market.
Based on end users, the molecular cytogenetics market is classified into clinical and research laboratories, academic research institutes, pharmaceutical and biotechnology companies, and others. The clinical and research laboratories segment is expected to account for the largest share of the global molecular cytogenetics market in 2016. The large number of molecular cytogenetic tests performed in clinical and research laboratories will drive the growth of this market during the forecast period.
Geographically, North America dominates the global molecular cytogenetics market. Growth in the North American segment is primarily driven by the rapid growth in the aging population and increasing incidence of genetic disorders and cancer.

The major factors contributing to the growth of the global molecular cytogenetics market include the increasing incidence of genetic disorders and cancer, growing usage of molecular cytogenetic techniques in clinical pathological testing, and rising aging population. On the other hand, high cost of advanced instruments and unfavorable reimbursement scenario are the major factors restraining the growth of this market. The high growth potential in the Asian region provides opportunities for players in the molecular cytogenetics market.

The major players in the molecular cytogenetics market are F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Abbott Laboratories (U.S.), Agilent Technologies (U.S.), PerkinElmer, Inc. (U.S.), Illumina, Inc. (U.S.), Bio-Rad Laboratories (U.S.), Oxford Gene Technology (U.K.), and Applied Spectral Imaging (U.S.).

Research Coverage
Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by players to maintain and increase their shares in the market.

Reasons to Buy the Report:
This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Companies purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on the product portfolios of the top players in the molecular cytogenetics market. The report analyses the molecular cytogenetics market by product, technique, application, and end user.
• Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the molecular cytogenetics market
• Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the molecular cytogenetics market
• Market Development: Comprehensive information about emerging markets. This report analyzes the market for molecular cytogenetics across geographies
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the molecular cytogenetics market

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 13
1.1 OBJECTIVES OF THE STUDY 13
1.2 MARKET DEFINITION 13
1.3 MARKETS COVERED 14
1.3.1 YEARS CONSIDERED FOR THE STUDY 14
1.4 CURRENCY 15
1.5 LIMITATIONS 15
1.6 STAKEHOLDERS 15
2 RESEARCH METHODOLOGY 16
2.1 SECONDARY DATA 17
2.1.1 KEY DATA FROM SECONDARY SOURCES 17
2.2 PRIMARY DATA 18
2.2.1 KEY DATA FROM PRIMARY SOURCES 19
2.3 MARKET SIZE ESTIMATION 20
2.3.1 BOTTOM-UP APPROACH 20
2.3.2 TOP-DOWN APPROACH 21
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 22
2.5 ASSUMPTIONS FOR THE STUDY 23
3 EXECUTIVE SUMMARY 24
3.1 CONCLUSION 29
4 PREMIUM INSIGHTS 30
4.1 MOLECULAR CYTOGENETICS: MARKET OVERVIEW 30
4.2 GEOGRAPHIC ANALYSIS: MOLECULAR CYTOGENETICS MARKET, BY TECHNIQUES 31
4.3 MOLECULAR CYTOGENETICS MARKET SIZE, BY APPLICATION 32
5 MARKET OVERVIEW 34
5.1 INTRODUCTION 35
5.2 MARKET DYNAMICS 35
5.2.1 MARKET DRIVERS 36
5.2.1.1 Increasing incidence of genetic disorders and cancer 36
5.2.1.2 Growing focus on targeted cancer treatment 37
5.2.1.3 Increasing aging population and subsequent rise in prevalence of chronic diseases 38
5.2.1.4 Increasing penetration of molecular cytogenetics in clinical pathological testing 38

5.2.2 MARKET RESTRAINTS 39
5.2.2.1 High cost of advanced instruments 39
5.2.2.2 Unfavourable reimbursement scenario 39
5.2.3 MARKET OPPORTUNITIES 40
5.2.3.1 Untapped emerging markets in Asia 40
5.2.4 MARKET TRENDS 40
5.2.4.1 Transition from FISH to Array-based techniques 40
6 MOLECULAR CYTOGENETICS MARKET, BY PRODUCT 41
6.1 INTRODUCTION 42
6.2 KITS & REAGENTS 44
6.2.1 TESTING KITS 45
6.2.2 PROBES 46
6.2.3 FLUORESCENT AFFINITY REAGENTS 46
6.2.4 OTHER KITS & REAGENTS 47
6.3 INSTRUMENTS 48
6.4 CONSUMABLES 49
6.5 SOFTWARE & SERVICES 49
7 MOLECULAR CYTOGENETICS MARKET, BY TECHNIQUE 51
7.1 INTRODUCTION 52
7.2 COMPARATIVE GENOMIC HYBRIDIZATION 53
7.2.1 ARRAY-BASED COMPARATIVE GENOMIC HYBRIDIZATION 55
7.2.2 STANDARD COMPARATIVE GENOMIC HYBRIDIZATION 56
7.3 FLUORESCENCE IN SITU HYBRIDIZATION 57
7.4 IN SITU HYBRIDIZATION 58
7.5 OTHER TECHNIQUES 59
8 MOLECULAR CYTOGENETICS MARKET, BY APPLICATION 60
8.1 INTRODUCTION 61
8.2 GENETIC DISORDERS 62
8.3 CANCER 63
8.4 PERSONALIZED MEDICINE 64
8.5 OTHER APPLICATIONS 65
9 MOLECULAR CYTOGENETICS MARKET, BY END USER 66
9.1 INTRODUCTION 67
9.2 CLINICAL & RESEARCH LABORATORIES 68
9.3 ACADEMIC RESEARCH INSTITUTES 69
9.4 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 70
9.5 OTHER END USERS 71
10 MOLECULAR CYTOGENETICS MARKET, BY REGION 72
10.1 INTRODUCTION 73
10.2 NORTH AMERICA 75
10.2.1 U.S. 80
10.2.2 CANADA 83
10.3 EUROPE 85
10.4 ASIA 88
10.4.1 CHINA 93
10.4.2 JAPAN 96
10.4.3 INDIA 99
10.4.4 ROA 102
10.5 REST OF THE WORLD (ROW) 105
11 COMPETITIVE LANDSCAPE 109
11.1 INTRODUCTION 109
11.2 STRATEGIC OVERVIEW 109
11.3 MARKET SHARE ANALYSIS 110
11.4 COMPETITIVE SITUATION AND TRENDS 111
11.4.1 COLLABORATIONS, AGREEMENTS, AND PARTNERSHIPS 112
11.4.2 NEW PRODUCT LAUNCHES 113
11.4.3 ACQUISITIONS 114
11.4.4 EXPANSIONS 114
11.4.5 OTHER DEVELOPMENTS 115
12 COMPANY PROFILES 116
(Company at a Glance, Recent Financials, Products & Services, Strategies & Insights, & Recent Developments)*
12.1 INTRODUCTION 116
12.2 ABBOTT LABORATORIES, INC. 117
12.3 AGILENT TECHNOLOGIES, INC. 119
12.4 APPLIED SPECTRAL IMAGING 122
12.5 BIO-RAD LABORATORIES, INC. 123
12.6 DANAHER CORPORATION 125
12.7 ILLUMINA, INC. 127
12.8 OXFORD GENE TECHNOLOGY (OGT) 129
12.9 PERKINELMER, INC. 131
12.10 F. HOFFMANN-LA ROCHE LTD. 133
12.11 THERMO FISHER SCIENTIFIC INC. 136
*Details on company at a glance, recent financials, products & services, strategies & insights, & recent developments might not be captured in case of unlisted companies.
13 APPENDIX 138
13.1 INSIGHTS OF INDUSTRY EXPERTS 138
13.2 DISCUSSION GUIDE 139
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 142
13.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 144
13.5 AVAILABLE CUSTOMIZATIONS 146
13.6 RELATED REPORTS 146
13.7 AUTHOR DETAILS 147

LIST OF TABLES

TABLE 1 PREVALENCE OF GENETIC DISORDERS (2012) 36
TABLE 2 INCIDENCE OF CANCER, BY COUNTRY (2012) 37
TABLE 3 MOLECULAR CYTOGENETICS MARKET SIZE, BY PRODUCT,
2014–2021 (USD MILLION) 43
TABLE 4 MOLECULAR CYTOGENETICS KITS AND REAGENTS MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 44
TABLE 5 MOLECULAR CYTOGENETICS KITS AND REAGENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 45
TABLE 6 MOLECULAR CYTOGENETICS MARKET SIZE FOR TESTING KITS, BY REGION,
2014–2021 (USD MILLION) 45
TABLE 7 MOLECULAR CYTOGENETICS MARKET SIZE FOR PROBES, BY REGION,
2014–2021 (USD MILLION) 46
TABLE 8 MOLECULAR CYTOGENETICS MARKET SIZE FOR FLUORESCENT AFFINITY REAGENTS, BY REGION, 2014–2021 (USD MILLION) 47
TABLE 9 MOLECULAR CYTOGENETICS MARKET SIZE FOR OTHER KITS AND REAGENTS,
BY REGION, 2014–2021 (USD MILLION) 47
TABLE 10 MOLECULAR CYTOGENETICS INSTRUMENTS MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 48
TABLE 11 MOLECULAR CYTOGENETICS CONSUMABLES MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 49
TABLE 12 MOLECULAR CYTOGENETICS SOFTWARE AND SERVICES MARKET SIZE,
BY REGION, 2014–2021 (USD MILLION) 50
TABLE 13 MOLECULAR CYTOGENETICS MARKET SIZE, BY TECHNIQUE,
2014–2021 (USD MILLION) 53
TABLE 14 COMPARATIVE GENOMIC HYBRIDIZATION MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 54
TABLE 15 COMPARATIVE GENOMIC HYBRIDIZATION MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 55
TABLE 16 ARRAY-BASED COMPARATIVE GENOMIC HYBRIDIZATION MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 55
TABLE 17 STANDARD COMPARATIVE GENOMIC HYBRIDIZATION MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 56
TABLE 18 FLUORESCENCE IN SITU HYBRIDIZATION MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 57
TABLE 19 IN SITU HYBRIDIZATION MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 58
TABLE 20 OTHER MOLECULAR CYTOGENETICS TECHNIQUES MARKET SIZE,
BY REGION, 2014–2021 (USD MILLION) 59
TABLE 21 MOLECULAR CYTOGENETICS MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 62
TABLE 22 GLOBAL MOLECULAR CYTOGENETICS MARKET SIZE FOR GENETIC DISORDERS,
BY REGION, 2014–2021 (USD MILLION) 63
TABLE 23 MOLECULAR CYTOGENETICS MARKET SIZE FOR CANCER, BY REGION,
2014–2021 (USD MILLION) 64
TABLE 24 MOLECULAR CYTOGENETICS MARKET SIZE FOR PERSONALIZED MEDICINE,
BY REGION, 2014–2021 (USD MILLION) 65
TABLE 25 OTHER MOLECULAR CYTOGENETICS APPLICATIONS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 65
TABLE 27 MOLECULAR CYTOGENETICS MARKET SIZE FOR CLINICAL AND RESEARCH LABORATORIES, BY REGION, 2014–2021 (USD MILLION) 69
TABLE 29 MOLECULAR CYTOGENETICS MARKET SIZE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2014–2021 (USD MILLION) 71
TABLE 30 MOLECULAR CYTOGENETICS MARKET SIZE FOR OTHER END USERS, BY REGION, 2014–2021 (USD MILLION) 71
TABLE 31 MOLECULAR CYTOGENETICS MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 74
TABLE 32 LIST OF RELATED CONFERENCES HELD IN NORTH AMERICA 75
TABLE 33 NORTH AMERICA: MOLECULAR CYTOGENETICS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 77
TABLE 34 NORTH AMERICA: MOLECULAR CYTOGENETICS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 78
TABLE 35 NORTH AMERICA: MOLECULAR CYTOGENETICS MARKET SIZE, BY TECHNIQUE, 2014–2021 (USD MILLION) 79
TABLE 36 NORTH AMERICA: MOLECULAR CYTOGENETICS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 79
TABLE 37 NORTH AMERICA: MOLECULAR CYTOGENETICS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 80
TABLE 38 U.S.: MOLECULAR CYTOGENETICS MARKET SIZE, BY PRODUCT,
2014–2021 (USD MILLION) 81
TABLE 39 U.S.: MOLECULAR CYTOGENETICS MARKET SIZE, BY TECHNIQUE,
2014–2021 (USD MILLION) 81
TABLE 40 U.S.: MOLECULAR CYTOGENETICS MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 82
TABLE 41 U.S.: MOLECULAR CYTOGENETICS MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 82
TABLE 42 CANADA: MOLECULAR CYTOGENETICS MARKET SIZE, BY PRODUCT,
2014–2021 (USD MILLION) 83
TABLE 43 CANADA: MOLECULAR CYTOGENETICS MARKET SIZE, BY TECHNIQUE,
2014–2021 (USD MILLION) 84
TABLE 44 CANADA: MOLECULAR CYTOGENETICS MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 84
TABLE 45 CANADA: MOLECULAR CYTOGENETICS MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 85
TABLE 46 EUROPE: MOLECULAR CYTOGENETICS MARKET SIZE, BY PRODUCT,
2014–2021 (USD MILLION) 86
TABLE 47 EUROPE: MOLECULAR CYTOGENETICS MARKET SIZE, BY TECHNIQUE,
2014–2021 (USD MILLION) 87
TABLE 48 EUROPE: MOLECULAR CYTOGENETICS MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 87
TABLE 49 EUROPE: MOLECULAR CYTOGENETICS MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 88
TABLE 50 ASIA: MOLECULAR CYTOGENETICS MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 90
TABLE 51 ASIA: MOLECULAR CYTOGENETICS MARKET SIZE, BY PRODUCT,
2014–2021 (USD MILLION) 91
TABLE 52 ASIA: MOLECULAR CYTOGENETICS MARKET SIZE, BY TECHNIQUE,
2014–2021 (USD MILLION) 92
TABLE 53 ASIA: MOLECULAR CYTOGENETICS MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 92
TABLE 54 ASIA: MOLECULAR CYTOGENETICS MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 93
TABLE 55 CHINA: MOLECULAR CYTOGENETICS MARKET SIZE, BY PRODUCT,
2014–2021 (USD MILLION) 94
TABLE 56 CHINA: MOLECULAR CYTOGENETICS MARKET SIZE, BY TECHNIQUE,
2014–2021 (USD MILLION) 95
TABLE 57 CHINA: MOLECULAR CYTOGENETICS MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 95
TABLE 58 CHINA: MOLECULAR CYTOGENETICS MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 96
TABLE 59 JAPAN: MOLECULAR CYTOGENETICS MARKET SIZE, BY PRODUCT,
2014–2021 (USD MILLION) 97
TABLE 60 JAPAN: MOLECULAR CYTOGENETICS MARKET SIZE, BY TECHNIQUE,
2014–2021 (USD MILLION) 98
TABLE 61 JAPAN: MOLECULAR CYTOGENETICS MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 98
TABLE 62 JAPAN: MOLECULAR CYTOGENETICS MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 99
TABLE 63 INDIA: MOLECULAR CYTOGENETICS MARKET SIZE, BY PRODUCT,
2014–2021 (USD MILLION) 100
TABLE 64 INDIA: MOLECULAR CYTOGENETICS MARKET SIZE, BY TECHNIQUE,
2014–2021 (USD MILLION) 101
TABLE 65 INDIA: MOLECULAR CYTOGENETICS MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 101
TABLE 66 INDIA: MOLECULAR CYTOGENETICS MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 102
TABLE 67 ROA: MOLECULAR CYTOGENETICS MARKET SIZE, BY PRODUCT,
2014–2021 (USD MILLION) 103
TABLE 68 ROA: MOLECULAR CYTOGENETICS MARKET SIZE, BY TECHNIQUE,
2014–2021 (USD MILLION) 104
TABLE 69 ROA: MOLECULAR CYTOGENETICS MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 104
TABLE 70 ROA: MOLECULAR CYTOGENETICS MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 105
TABLE 71 ROW: MOLECULAR CYTOGENETICS MARKET SIZE, BY PRODUCT,
2014–2021 (USD MILLION) 106
TABLE 72 ROW: MOLECULAR CYTOGENETICS MARKET SIZE, BY TECHNIQUE,
2014–2021 (USD MILLION) 107
TABLE 73 ROW: MOLECULAR CYTOGENETICS MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 107
TABLE 74 ROW: MOLECULAR CYTOGENETICS MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 108
TABLE 75 GROWTH STRATEGY MATRIX, (2014–2016) 111
TABLE 76 COLLABORATIONS, AGREEMENTS, AND PARTNERSHIPS (2014–2016) 112
TABLE 77 NEW PRODUCT LAUNCHES (2014–2016) 113
TABLE 78 ACQUISITIONS (2014–2016) 114
TABLE 79 EXPANSIONS (2014–2016) 114
TABLE 80 OTHER DEVELOPMENTS (2014–2016) 115


LIST OF FIGURES

FIGURE 1 GLOBAL MOLECULAR CYTOGENETICS MARKET 14
FIGURE 2 RESEARCH DESIGN 16
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 18
FIGURE 4 MOLECULAR CYTOGENETICS MARKET: BOTTOM-UP APPROACH 20
FIGURE 5 MOLECULAR CYTOGENETICS MARKET: TOP-DOWN APPROACH 21
FIGURE 6 DATA TRIANGULATION METHODOLOGY 22
FIGURE 7 GLOBAL MOLECULAR CYTOGENETICS MARKET SIZE, BY PRODUCT,
2016 VS. 2021 (USD MILLION) 24
FIGURE 8 GLOBAL MOLECULAR CYTOGENETICS MARKET SIZE, BY TECHNIQUE,
2016 VS. 2021 (USD MILLION) 25
FIGURE 9 GLOBAL MOLECULAR CYTOGENETICS MARKET SIZE, BY APPLICATION,
2016 VS. 2021 (USD MILLION) 26
FIGURE 10 GLOBAL MOLECULAR CYTOGENETICS MARKET SIZE, BY END USER,
2016 VS. 2021 (USD MILLION) 27
FIGURE 11 GEOGRAPHIC SNAPSHOT OF THE GLOBAL MOLECULAR CYTOGENETICS MARKET 28
FIGURE 12 GLOBAL MOLECULAR CYTOGENETICS MARKET TO WITNESS DOUBLE-DIGIT GROWTH DURING THE FORECAST PERIOD 30
FIGURE 13 COMPARATIVE GENOMIC HYBRIDIZATION SEGMENT TO DOMINATE THE GLOBAL MOLECULAR CYTOGENETICS MARKET IN 2016 31
FIGURE 14 GENETIC DISORDERS SEGMENT WILL CONTINUE TO DOMINATE THE MOLECULAR CYTOGENETICS MARKET IN 2021 32
FIGURE 15 ASIA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 33
FIGURE 16 MOLECULAR CYTOGENETICS MARKET: DRIVERS, RESTRAINTS,
OPPORTUNITIES, AND TRENDS 35
FIGURE 17 MOLECULAR CYTOGENETICS MARKET SEGMENTATION, BY PRODUCT 42
FIGURE 18 KITS AND REAGENTS WILL CONTINUE TO DOMINATE THE MOLECULAR CYTOGENETICS PRODUCTS MARKET DURING THE FORECAST PERIOD 43
FIGURE 19 COMPARATIVE GENOMIC HYBRIDIZATION TO DOMINATE THE MOLECULAR CYTOGENETICS MARKET DURING THE FORECAST PERIOD 52
FIGURE 20 ARRAY-BASED CGH WILL CONTINUE TO DOMINATE THE CGH MARKET DURING THE FORECAST PERIOD 54
FIGURE 21 GENETIC DISORDERS APPLICATIONS SEGMENT TO DOMINATE THE MOLECULAR CYTOGENETICS MARKET DURING THE FORECAST PERIOD 61
FIGURE 22 CLINICAL AND RESEARCH LABORATORIES TO DOMINATE THE MOLECULAR CYTOGENETICS END-USER MARKET DURING THE FORECAST PERIOD 67
FIGURE 23 MOLECULAR CYTOGENETICS MARKET, BY REGION (MARKET SIZE AND
GROWTH RATE), 2016 73
FIGURE 24 MOLECULAR CYTOGENETICS MARKET IN EUROPE TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD 74
FIGURE 25 NORTH AMERICA: MOLECULAR CYTOGENETICS MARKET SNAPSHOT 76
FIGURE 26 U.S. TO DOMINATE THE NORTH AMERICAN MARKET IN 2016 77
FIGURE 27 KITS AND REAGENTS, THE LARGEST PRODUCT SEGMENT IN THE NORTH AMERICAN MOLECULAR CYTOGENETICS MARKET IN 2016 78
FIGURE 28 KITS & REAGENTS ARE ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN THE EUROPEAN MOLECULAR CYTOGENETICS MARKET IN 2016 86
FIGURE 29 ASIA: MOLECULAR CYTOGENETICS MARKET SNAPSHOT 89
FIGURE 30 CHINA IS ESTIMATED TO DOMINATE THE ASIAN MOLECULAR CYTOGENETICS MARKET IN 2016 90
FIGURE 31 KITS AND REAGENTS TO GROW AT THE HIGHEST CAGR OF THE ASIAN MOLECULAR CYTOGENETICS MARKET, BY PRODUCT, IN 2016 91
FIGURE 32 KITS AND REAGENTS TO HOLD A MAJOR SHARE OF THE CHINESE MOLECULAR CYTOGENETICS MARKET, BY PRODUCT, IN 2016 94
FIGURE 33 KITS AND REAGENTS TO HOLD A MAJOR SHARE OF THE JAPANESE MOLECULAR CYTOGENETICS MARKET, BY PRODUCT, IN 2016 97
FIGURE 34 KITS AND REAGENTS TO HOLD A MAJOR SHARE OF THE INDIAN MOLECULAR CYTOGENETICS MARKET, BY PRODUCT, IN 2016 100
FIGURE 35 KITS AND REAGENTS TO HOLD A MAJOR SHARE OF THE ROA MOLECULAR CYTOGENETICS MARKET, BY PRODUCT, IN 2016 103
FIGURE 36 KITS AND REAGENTS SEGMENT TO GROW AT THE HIGHEST CAGR IN THE
ROW MARKET 106
FIGURE 37 COLLABORATIONS, AGREEMENTS AND PARTNERSHIPS WERE THE KEY STRATEGIES ADOPTED BY PLAYERS IN THE MOLECULAR CYTOGENETICS MARKET 109
FIGURE 38 MOLECULAR CYTOGENETICS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015 110
FIGURE 39 GEOGRAPHIC REVENUE MIX OF THE TOP MARKET PLAYERS 116
FIGURE 40 COMPANY SNAPSHOT: ABBOTT LABORATORIES, INC. 117
FIGURE 41 COMPANY SNAPSHOT: AGILENT TECHNOLOGIES, INC. 119
FIGURE 42 COMPANY SNAPSHOT: BIO-RAD LABORATORIES, INC. 123
FIGURE 43 COMPANY SNAPSHOT: DANHER CORPORATION 125
FIGURE 44 COMPANY SNAPSHOT: ILLUMINA, INC. 127
FIGURE 45 COMPANY SNAPSHOT: PERKINELMER, INC. 131
FIGURE 46 COMPANY SNAPSHOT: F. HOFFMANN-LA ROCHE LTD. 133
FIGURE 47 COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC INC. 136






★調査レポート[分子細胞遺伝学の世界市場予測(~2021):製品別(キット、試薬、プローブ、消耗品、ソフトウェア、サービス)、技術別(ハイブリダイゼーション法(In-Situ)、蛍光染色体ハイブリッド形成(FISH)、比較ゲノムハイブリダイゼーション)、用途別(がん、遺伝)、エンドユーザー別(研究室、研究機関)] ( Molecular Cytogenetics Market by Product (Kit, Reagent, Probe, Consumable, Software, Service), Technique (In-Situ, FISH, Comparative Genomic Hybridization), Application (Cancer, Genetic), End User (Research Labs, Institutes) - Forecast to 2021 / MAM-BT-4883) 販売に関する免責事項
[分子細胞遺伝学の世界市場予測(~2021):製品別(キット、試薬、プローブ、消耗品、ソフトウェア、サービス)、技術別(ハイブリダイゼーション法(In-Situ)、蛍光染色体ハイブリッド形成(FISH)、比較ゲノムハイブリダイゼーション)、用途別(がん、遺伝)、エンドユーザー別(研究室、研究機関)] ( Molecular Cytogenetics Market by Product (Kit, Reagent, Probe, Consumable, Software, Service), Technique (In-Situ, FISH, Comparative Genomic Hybridization), Application (Cancer, Genetic), End User (Research Labs, Institutes) - Forecast to 2021 / MAM-BT-4883) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆